Biomerica (Biomerica) EBIT per Share : $-0.40 (TTM As of Feb. 2024)

View and export this data going back to 1978. Start your Free Trial

What is Biomerica EBIT per Share?

Biomerica's EBIT per Share for the three months ended in Feb. 2024 was $-0.12. Its EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2024 was $-0.40.

During the past 3 years, the average EBIT per Share Growth Rate was -23.60% per year. During the past 5 years, the average EBIT per Share Growth Rate was -22.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Biomerica's EBIT per Share or its related term are showing as below:

BMRA' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -53.8 Med: -9 Max: 64.9
Current: -23.6

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Biomerica was 64.90% per year. The lowest was -53.80% per year. And the median was -9.00% per year.

BMRA's 3-Year EBIT Growth Rate is ranked worse than
81.97% of 721 companies
in the Medical Devices & Instruments industry
Industry Median: 6.7 vs BMRA: -23.60

Biomerica's EBIT for the three months ended in Feb. 2024 was $-2.00 Mil.

Biomerica EBIT per Share Historical Data

The historical data trend for Biomerica's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomerica EBIT per Share Chart

Biomerica Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

EBIT per Share

Get a 7-Day Free Trial

-0.26

-0.62

-0.36

-0.51

Biomerica Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EBIT per Share	Get a 7-Day Free Trial															-0.12	-0.11	-0.07	-0.10	-0.12

Biomerica EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Biomerica's EBIT per Share for the fiscal year that ended in May. 2023 is calculated as

	EBIT per Share		(A: May. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-7.223	/	14.154
=	-0.51

Biomerica's EBIT per Share for the quarter that ended in Feb. 2024 is calculated as

	EBIT per Share		(Q: Feb. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-2	/	16.822
=	-0.12

EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.40

Biomerica (NAS:BMRA) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Biomerica EBIT per Share Related Terms

Thank you for viewing the detailed overview of Biomerica's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomerica (Biomerica) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biomerica Inc (NAS:BMRA) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

17571 Von Karman Avenue, Irvine, CA, USA, 92614

Website

https://www.biomerica.com

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.

Executives

John P. Kenny	director	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Zacharys Irani	director, officer: Cheif Executive Officer	17571 VON KARMAN AVE., IRVINE CA 92614
Gary Lu	officer: Chief Financial Officer	12136 AHERN CT, TUSTIN CA 92782
Allen Barbieri	director
Catherine Coste	director	966 OCHO RIOS DR, DANVILLE CA 94526
David Moatazedi	director	C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Steven Sloan	officer: Chief Financial Officer	114 TERRAPIN, IRVINE CA 92618
Mark A Sirgo	director	C/O BIODELIVERY SCIENCES INTERNATIONAL, 801 CORPORATE CENTER DRIVE -SUITE 210, RALEIGH NC 27607
Francis Cano	director	11 ACORN LANE, LOS ALTOS CA 94022
Francis E Capitanio	officer: President-diagnostics	1533 MONROVIA AVENUE, NEWPORT BEACH CA 92663
Janet Moore	director, 10 percent owner, officer: Secretary	1533 MUNROVIA AVE, NEWPORT BEACH CA 92663
Jane Emerson	director	1533 MONROVIA AVE, NEWPORT BEACH CA 92663
William Snider	other: Greater than 5% holder	4800 MONTGOMERY LANE, SUITE 230, BETHESDA MD 20814
Broadoak Fund The	other: Greater than 5% holder	7201 WISCONSIN AVE. #630, BETHESDA MD 20814
John Roehm	director	1533 MONROVIA AVE., NEWPORT BEACH CA 92663